000919.SZ · 金陵药业
China A-shares · RS rating 67 · As of 2026-10-14
| Price | 6.46 CNY |
|---|---|
| 1-day change | -1.8% |
| RS rating (overall / 1M / 3M / 12M) | 67 / 68 / 70 / 63 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 22 / 23 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +6.1% |
| Distance from 52-week high | +27.5% |
| Market cap (USD) | $620.4M |